

share
6-Demethylgriseofulvin CAS NO 20168-88-1
Unit Price:
CAS No.:20168-88-1
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
6-Demethylgriseofulvin is a key intermediate and derivative of the antifungal agent griseofulvin, distinguished by its modified molecular structure. This compound is of significant interest in pharmaceutical research and development for the synthesis of novel antifungal agents and for structure-activity relationship (SAR) studies. It serves as a critical building block for researchers and manufacturers in the pharmaceutical and fine chemical sectors who require high-purity intermediates for advanced synthesis.
Application
- Pharmaceutical Intermediate: Serves as a crucial precursor in the synthesis of griseofulvin analogs and novel antifungal compounds.
- Research & Development: Used in academic and industrial laboratories for pharmacological studies and structure-activity relationship (SAR) investigations.
- Reference Standard: Employed as an analytical standard in quality control laboratories for method development and impurity profiling.
- Biochemical Research: Utilized in studies exploring the mechanism of action of griseofulvin and its derivatives on fungal cell mitosis.
- Fine Chemical Synthesis: Acts as a specialized building block for the preparation of more complex, biologically active molecules.
Basic Information
| Product Name | 6-Demethylgriseofulvin |
| CAS No. | 20168-88-1 |
| Molecular Formula | C16H16ClO6 |
| Molecular Weight | 348.75 g/mol |
| Synonyms | 6-Desmethylgriseofulvin; 7-Chloro-4,6-dimethoxy-6'-methyl-3H,4'H-spiro[1-benzofuran-2,1'-cyclohex[2]ene]-3,4'-dione; Griseofulvin Impurity; NSC 51046; Griseofulvin Derivative; De(methyl)griseofulvin |
| EINECS | Contact for details |
Quality Control
Our 6-Demethylgriseofulvin is produced under a rigorous quality management system. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation, to ensure it meets exacting standards for research and synthesis. Certificates of Analysis (COA) with detailed chromatographic data are available upon request.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). The product is light-sensitive and should be handled accordingly to maintain stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (IR) | Conforms to structure |
| Purity (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 0.5% |
| Residue on Ignition | ≤ 0.1% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pregabalin Ep Impurity A CAS NO 181289-23-6


Sulfamethazine-N4-Acetyl CAS NO 100-90-3


Pseudomorphine (Morphine Impurity) CAS NO 125-24-6


Dextrorphan D-Tartrate CAS NO 125-73-5


8-Acetyl Ludaconitine CAS NO 127-29-7


Oxythiamine Hydrochloride CAS NO 136-16-3


Dl-Normetanephrine Hydrochloride CAS NO 1011-74-1


Hydrochlorothiazide Impurity G CAS NO 1025-75-8


Prednisone Impurity 24 CAS NO 1058-04-4


Cinepazide Impurity 5 CAS NO 1078-64-4


n-Nitrosodiethanolamine CAS NO 1116-54-7


10-Hydroxynortriptyline CAS NO 1156-99-6


Nicorandil Impurity 16 CAS NO 1157-74-0


16-Dehydro Pregnenolone Acetate Impurity 3 CAS NO 1173-11-1


17Beta-Hydroxy-4-Androsten-3-One 17-D-Glucuronide CAS NO 1180-25-2


6,6',12'-Trimethoxy-2-Methyloxyacanthan-7-Ol CAS NO 1183-76-2


Thiamine Impurity 27 CAS NO 1196-75-4


4-Hydroxytriamterene CAS NO 1226-52-4


Betamethasone Impurity 7 CAS NO 1249-19-0


Benzocaine Impurity D CAS NO 1333-08-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






